In patients refractory to anti‐TNF‐α treatment, a distinct subset of TNFR2+IL23R+CD4+ T cells with heightened IL‐23 receptor expression has been implicated in anti‐TNF‐α treatment molecular resistance in CD.10 Here, IL23R is linked to Cowden disease.